Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.

ABSTRACT:

SUBMITTER: Kasikis S 

PROVIDER: S-EPMC9840529 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature